Under the Pharmaceutical Price Regulation Scheme, branded-drug companies are allowed to make a profit of up to 21 per cent on any medicines they sell to the NHS. They have a freehand to set the prices when they are introduced but, every five years, the government and the companies agree an across-the-board cut on all drugs.